AI Score

Unlock

Myomo Inc. (MYO)

AI Score

Unlock

5.30

-0.14 (-2.57%)

At close: Mar 18, 2025, 3:59 PM

5.35

0.95%

After-hours: Mar 18, 2025, 08:00 PM EDT

-2.57% (1D)

Bid	5.1
Market Cap	182.22M
Revenue (ttm)	27.82M
Net Income (ttm)	-5.28M
EPS (ttm)	-0.16
PE Ratio (ttm)	-33.12
Forward PE	-71.51
Analyst	Strong Buy

Ask	5.6
Volume	522,742
Avg. Volume (20D)	467,529
Open	5.29
Previous Close	5.44
Day's Range	5.17 - 5.38
52-Week Range	2.51 - 7.17
Beta	1.60

About MYO

Myomo, Inc., a wearable medical robotics company, designs, develops, and produces myoelectric orthotics for people with neuromuscular disorders in the United States. The company offers MyoPro, a myoelectric-controlled upper limb brace or orthosis product used for supporting a patient's weak or paralyzed arm to enable and improve functional activities of daily living. Its products are designed to help improve function in adults and adolescents wit...

[Show more]

Industry Medical - Devices

Sector Healthcare

IPO Date Jun 12, 2017

Employees 184

Stock Exchange NYSE

Ticker Symbol MYO

Website https://www.myomo.com

Full Company Profile

Analyst Forecast

According to 4 analyst ratings, the average rating for MYO stock is "Strong Buy." The 12-month stock price forecast is $10.25, which is an increase of 93.40% from the latest price.

Stock Forecasts

Earnings Surprise

Myomo has released their quartely earnings on Mar 10, 2025:

Revenue of $12.07M exceeds estimates by $2.17M, with 153.74% YoY growth.

EPS of -0.01 exceeds estimates by 0.01, with 85.71% YoY growth.

Next Earnings Release

Myomo Inc. is scheduled to release its earnings on May 7, 2025, during market hours.
Analysts project revenue of ... Unlock content with Pro Subscription

Why Price Moved

1 week ago

+40.77%

Myomo shares are trading higher after the company ... Unlock content with Pro Subscription

1 week ago

-9.35%

Myomo shares are trading higher after the company reported better-than-expected Q4 financial results.

News

1 week ago · zacks.com

Myomo, Inc. (MYO) Reports Q4 Loss, Tops Revenue Estimates

Myomo, Inc. (MYO) came out with a quarterly loss of $0.01 per share versus the Zacks Consensus Estimate of a loss of $0.02. This compares to loss of $0.07 per share a year ago.

1 week ago · seekingalpha.com

Myomo, Inc. (MYO) Q4 2024 Earnings Call Transcript

Myomo, Inc. (NYSE:MYO ) Q4 2024 Earnings Conference Call March 10, 2025 4:30 PM ET Company Participants Tirth Patel - Alliance Advisors, Investor Relations Paul Gudonis - Chief Executive Officer Dave ...

1 week ago · businesswire.com

Myomo's Fourth Quarter Financial Results Feature Record Revenue of $12.1 Million

BURLINGTON, Mass.--(BUSINESS WIRE)--Myomo, Inc. (NYSE American: MYO) (“Myomo” or the “Company”), a wearable medical robotics company that offers increased functionality for those suffering from neurol...

2 weeks ago · businesswire.com

Myomo to Report Fourth Quarter 2024 Financial Results on March 10

1 month ago · marketbeat.com

3 Underrated Robotics Stocks Poised for Major Growth

The days of robots being primarily limited to manufacturing applications are long gone—the industry is expanding rapidly and becoming integrated into many different sectors thanks to rapid development...